We are live on ! Find out more
Balyasny Asset Management

Balyasny Asset Management Portfolio holdings

AUM $77.1B
1-Year Est. Return 42.89%
This Fund
S&P 500
This Quarter Est. Return
+7.45%
1 Year Est. Return
+42.89%
3 Year Est. Return
+126.29%
5 Year Est. Return
+172.74%
10 Year Est. Return
+1,026.86%
AUM
$32B
AUM Growth
+$6.48B
Cap. Flow
+$4.77B
Cap. Flow %
14.9%
Top 10 Hldgs %
10.84%
Holding
2,554
New
720
Increased
686
Reduced
602
Closed
529

Sector Composition

Rank Sector Weight
1 Financials 20.47%
2 Consumer Discretionary 12.5%
3 Healthcare 10.55%
4 Industrials 6.63%
5 Real Estate 6.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXAS
1926
DELISTED
Abraxas Petroleum Corp
AXAS
$183K ﹤0.01%
3,723
-345
-8% -$14.3K
ARDX icon
1927
Ardelyx
ARDX
$1.21B
$182K ﹤0.01%
27,603
+4,124
+18% +$24.4K
AKBA icon
1928
Akebia Therapeutics
AKBA
$346M
$179K ﹤0.01%
+12,049
New +$200K
CVA
1929
DELISTED
Covanta Holding Corporation
CVA
$176K ﹤0.01%
+10,401
New +$161K
ESI icon
1930
Element Solutions
ESI
$9.34B
$171K ﹤0.01%
17,277
-59,916
-78% -$622K
ANH
1931
DELISTED
Anworth Mortgage Asset Corporation
ANH
$166K ﹤0.01%
30,494
-42,903
-58% -$245K
RST
1932
DELISTED
ROSETTA STONE INC
RST
$166K ﹤0.01%
+13,302
New +$149K
AAC
1933
DELISTED
AAC Holdings
AAC
$166K ﹤0.01%
+18,397
New +$166K
CYTK icon
1934
Cytokinetics
CYTK
$10.7B
$162K ﹤0.01%
19,877
-822,118
-98% -$9.33M
MLNT
1935
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
$162K ﹤0.01%
+2,047
New +$151K
VNDA icon
1936
Vanda Pharmaceuticals
VNDA
$306M
$160K ﹤0.01%
10,500
-11,400
-52% -$169K
IMGN
1937
DELISTED
Immunogen Inc
IMGN
$160K ﹤0.01%
+24,978
New +$154K
PRMW
1938
DELISTED
Primo Water Corporation
PRMW
$159K ﹤0.01%
12,649
+2,323
+22% +$27.8K
ACET
1939
DELISTED
Aceto Corp
ACET
$157K ﹤0.01%
15,167
-9,423
-38% -$99K
ACTG icon
1940
Acacia Research
ACTG
$439M
$156K ﹤0.01%
38,597
+25,700
+199% +$109K
LPSN icon
1941
LivePerson
LPSN
$26.1M
$154K ﹤0.01%
+895
New +$168K
RIG icon
1942
Transocean
RIG
$5.69B
$152K ﹤0.01%
+14,215
New +$148K
SCWX
1943
DELISTED
SecureWorks Corp Class A Common Stock
SCWX
$151K ﹤0.01%
+16,989
New +$174K
GLDD
1944
DELISTED
Great Lakes Dredge & Dock
GLDD
$150K ﹤0.01%
+27,800
New +$141K
CROX icon
1945
Crocs
CROX
$6.58B
$148K ﹤0.01%
11,700
-21,500
-65% -$230K
MACK
1946
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$148K ﹤0.01%
+18,379
New +$171K
EVRI
1947
DELISTED
Everi Holdings
EVRI
$143K ﹤0.01%
19,021
-7,100
-27% -$57.2K
AVID
1948
DELISTED
Avid Technology Inc
AVID
$141K ﹤0.01%
+26,095
New +$140K
SIOX
1949
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$141K ﹤0.01%
3,350
-4,275
-56% -$192K
SECO
1950
DELISTED
Secoo Holding Limited ADR
SECO
$141K ﹤0.01%
1,458
-62,685
-98% -$5.27M

Similar funds

Balyasny Asset Management's Q4 2017 Portfolio in Review

As of Q4 2017, Balyasny Asset Management held 2,554 positions worth $32B, up 25% from $25.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Balyasny Asset Management deployed $4.77B of net new capital in Q4 2017, opening 720 new positions and adding to 686 existing holdings. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 1,700,000 shares worth $148M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was American Express, an estimated $253M trimmed.

  • Balyasny Asset Management's largest Q4 2017 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 1,700,000 shares worth $148M.
  • Balyasny Asset Management added most to Aetna Inc in Q4 2017, an estimated $175M increase.
  • Balyasny Asset Management's biggest Q4 2017 reduction was American Express, cutting an estimated $253M.
  • Balyasny Asset Management fully exited Range Resources in Q4 2017, selling an estimated $104M.
  • Balyasny Asset Management's ten largest holdings make up 11% of its $32B portfolio in Q4 2017.
  • Balyasny Asset Management opened 720 new positions and closed 529 in Q4 2017.
  • Balyasny Asset Management's portfolio value rose 25% quarter-over-quarter to $32B.

Based on Balyasny Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.